PubMed

Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.

Grover SA, Kaouache M, Joseph L, Barter P, Davignon J.

Arch Intern Med. 2009 Oct 26;169(19):1775-80.PMID: 19858435 [PubMed - indexed for MEDLINE]Related articles

Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study.

Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, Boudreau G.

J Gen Intern Med. 2009 Jan;24(1):33-9. Epub 2008 Oct 21.PMID: 18937013 [PubMed - indexed for MEDLINE]Related articles

Determining the cost-effectiveness of preventing cardiovascular disease: are estimates calculated over the duration of a clinical trial adequate?

Grover SA, Coupal L, Lowensteyn I.

Can J Cardiol. 2008 Apr;24(4):261-6.PMID: 18401465 [PubMed - indexed for MEDLINE]Related articlesFree article

Estimating the cost effectiveness of ramipril used for specific clinical indications: comparing the outcomes in four clinical trials with a common economic model.

Grover SA, Coupal L, Lowensteyn I.

Am J Cardiovasc Drugs. 2007;7(6):441-8.PMID: 18076211 [PubMed - indexed for MEDLINE]Related articles

Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.

Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, Boudreau G; Cardiovascular Health Evaluation to Improve Compliance and Knowledge Among Uninformed Patients (CHECK-UP) Study Group.

Arch Intern Med. 2007 Nov 26;167(21):2296-303.PMID: 18039987 [PubMed - indexed for MEDLINE]Related articlesFree article

Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?

Grover SA, Coupal L, Kaouache M, Lowensteyn I.

Can J Cardiol. 2007 May 1;23(6):467-73.PMID: 17487292 [PubMed - indexed for MEDLINE]Related articlesFree article

Barriers and remaining questions on assessment of absolute cardiovascular risk as a starting point for interventions to reduce cardiovascular risk.

Campbell NR, Khan NA, Grover SA.

J Hypertens. 2006 Sep;24(9):1683-5. No abstract available. PMID: 16915012 [PubMed - indexed for MEDLINE]Related articles

The role of global risk assessment in hypertension therapy.

Grover SA, Hemmelgarn B, Joseph L, Milot A, Tremblay G.

Can J Cardiol. 2006 May 15;22(7):606-13. Review.PMID: 16755316 [PubMed - indexed for MEDLINE]Related articlesFree article

PROVE-IT proves that lower is better: a contrary view.

Grover SA.

Can J Cardiol. 2006 Feb;22 Suppl B:95B-96B. Review.PMID: 16498520 [PubMed - indexed for MEDLINE]Related articles

The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.

Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, Zoccoli J, Defoy I.

Arch Intern Med. 2006 Jan 23;166(2):213-9.PMID: 16432091 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of modified glucose target and exercise interventions on vascular risk factors.

Dasgupta K, Grover SA, Da Costa D, Lowensteyn I, Yale JF, Rahme E.

Diabetes Res Clin Pract. 2006 Apr;72(1):53-60. Epub 2005 Oct 26.PMID: 16256242 [PubMed - indexed for MEDLINE]Related articles

Sulfonylurea use associated with reduction in blood glucose levels during exercise stress testing.

Dasgupta K, Grover SA, Lowensteyn I, Yale JF, Da Costa D, Rahme E.

J Cardiopulm Rehabil. 2005 Jul-Aug;25(4):222-5. No abstract available. PMID: 16056070 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of lipid-lowering treatment according to lipid level.

Pilote L, Ho V, Lavoie F, Coupal L, Zowall H, Grover SA.

Can J Cardiol. 2005 Jun;21(8):681-7.PMID: 16003451 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy.

Grover SA, Coupal L, Gilmore N, Mukherjee J.

Am J Cardiol. 2005 Mar 1;95(5):586-91.PMID: 15721096 [PubMed - indexed for MEDLINE]Related articles

Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?

Grover SA, Coupal L, Zowall H.

Hypertension. 2005 Jan;45(1):92-7. Epub 2004 Nov 15.PMID: 15545508 [PubMed - indexed for MEDLINE]Related articlesFree article

Development and preliminary testing of a patient decision aid to assist pharmaceutical care in the prevention of cardiovascular disease.

Lalonde L, O'Connor AM, Drake E, Duguay P, Lowensteyn I, Grover SA.

Pharmacotherapy. 2004 Jul;24(7):909-22.PMID: 15303454 [PubMed - indexed for MEDLINE]Related articles

Health-related quality of life in cardiac patients with dyslipidemia and hypertension.

Lalonde L, O'Connor A, Joseph L, Grover SA; Canadian Collaborative Cardiac Assessment Group.

Qual Life Res. 2004 May;13(4):793-804.PMID: 15129889 [PubMed - indexed for MEDLINE]Related articles

Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor.

Grover SA, Coupal L, Zowall H, Weiss TW, Alexander CM.

Am J Med. 2003 Aug 1;115(2):122-8.PMID: 12893398 [PubMed - indexed for MEDLINE]Related articles

Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol.

Grover SA, Dorais M, Coupal L.

Epidemiology. 2003 May;14(3):315-20.PMID: 12859032 [PubMed - indexed for MEDLINE]Related articles

Application of the 1998 Canadian cholesterol guidelines to a military population: health benefits and cost effectiveness of improved cholesterol management.

Spaans JN, Coyle D, Fodor G, Nair R, Vaillancourt R, Grover SA, Coupal L.

Can J Cardiol. 2003 Jun;19(7):790-6.PMID: 12813612 [PubMed - indexed for MEDLINE]Related articlesFree article

Costs of dyslipidemia.

Zowall H, Grover SA.

Expert Rev Pharmacoecon Outcomes Res. 2003 Jun;3(3):273-81.PMID: 19807375 [PubMed - in process]

The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?

Grover SA, Ho V, Lavoie F, Coupal L, Zowall H, Pilote L.

Arch Intern Med. 2003 Feb 10;163(3):333-9.PMID: 12578514 [PubMed - indexed for MEDLINE]Related articlesFree article

The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.

McAlister FA, Zarnke KB, Campbell NR, Feldman RD, Levine M, Mahon J, Grover SA, Lewanczuk R, Leenen F, Tobe S, Lebel M, Stone J, Schiffrin EL, Rabkin SW, Ogilvie RI, Larochelle P, Jones C, Honos G, Fodor G, Burgess E, Hamet P, Herman R, Irvine J, Culleton B, Wright JM; Canadian Hypertension Recommendations Working Group.

Can J Cardiol. 2002 Jun;18(6):625-41.PMID: 12107420 [PubMed - indexed for MEDLINE]Related articlesFree article

Automated hands-free image manipulation and viewing: a useful macro feature that assists radiologists in the viewing of chest and extremity digital radiographs.

Koenker RM, Grover SA.

J Digit Imaging. 2002;15 Suppl 1:166-70. Epub 2002 Mar 20.PMID: 12105720 [PubMed - indexed for MEDLINE]Related articles

Comparing the benefits of diet and exercise in the treatment of dyslipidemia.

Lalonde L, Gray-Donald K, Lowensteyn I, Marchand S, Dorais M, Michaels G, Llewellyn-Thomas HA, O'Connor A, Grover SA; Canadian Collaborative Cardiac Assessment Group.

Prev Med. 2002 Jul;35(1):16-24.PMID: 12079437 [PubMed - indexed for MEDLINE]Related articles

Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis.

White PD, Thomas JM, Kangro HO, Bruce-Jones WD, Amess J, Crawford DH, Grover SA, Clare AW.

Lancet. 2001 Dec 8;358(9297):1946-54.PMID: 11747919 [PubMed - indexed for MEDLINE]Related articles

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL.

Arthritis Rheum. 2001 Oct;44(10):2331-7.PMID: 11665973 [PubMed - indexed for MEDLINE]Related articles

Health-related quality of life with coronary heart disease prevention and treatment.

Lalonde L, Clarke AE, Joseph L, Mackenzie T, Grover SA; Canadian Collaborative Cardiac Assessment Group.

J Clin Epidemiol. 2001 Oct;54(10):1011-8.PMID: 11576812 [PubMed - indexed for MEDLINE]Related articles

A randomized management study of impedance plethysmography vs. contrast venography in patients with a first episode of clinically suspected deep vein thrombosis.

Kahn SR, Joseph L, Grover SA, Leclerc JR.

Thromb Res. 2001 Apr 1;102(1):15-24.PMID: 11323010 [PubMed - indexed for MEDLINE]Related articles

How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?

Grover SA, Coupal L, Zowall H, Alexander CM, Weiss TW, Gomes DR.

Diabetes Care. 2001 Jan;24(1):45-50.PMID: 11194239 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines.

Grover SA, Dorais M, Paradis G, Fodor JG, Frohlich JJ, McPherson R, Coupal L, Zowall H.

CMAJ. 2000 Nov 14;163(10):1263-9.PMID: 11107461 [PubMed - indexed for MEDLINE]Related articlesFree article

When should hypertension be treated? The different perspectives of Canadian family physicians and patients.

McAlister FA, O'Connor AM, Wells G, Grover SA, Laupacis A.

CMAJ. 2000 Aug 22;163(4):403-8.PMID: 10976255 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated?

Grover SA, Coupal L, Zowall H, Dorais M.

Circulation. 2000 Aug 15;102(7):722-7.PMID: 10942738 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost-effectiveness of exercise training for the primary and secondary prevention of cardiovascular disease.

Lowensteyn I, Coupal L, Zowall H, Grover SA.

J Cardiopulm Rehabil. 2000 May-Jun;20(3):147-55.PMID: 10860196 [PubMed - indexed for MEDLINE]Related articles

The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.

Grover SA, Coupal L, Zowall H, Rajan R, Trachtenberg J, Elhilali M, Chetner M, Goldenberg L.

CMAJ. 2000 Apr 4;162(7):987-92.PMID: 10763396 [PubMed - indexed for MEDLINE]Related articlesFree article

The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.

Grover SA, Coupal L, Zowall H, Rajan R, Trachtenberg J, Elhilali M, Chetner M, Goldenberg L.

CMAJ. 2000 Apr 4;162(7):977-83.PMID: 10763395 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of WHO-MONICA Project in unravelling of the cardiovascular puzzle.

Grover SA.

Lancet. 2000 Feb 26;355(9205):668-9. No abstract available. PMID: 10703793 [PubMed - indexed for MEDLINE]Related articles

The cost effectiveness of preventing cardiovascular diseases.

Grover SA.

Can J Cardiol. 1999 Dec;15 Suppl G:114G-6G. Review. No abstract available. PMID: 10692671 [PubMed - indexed for MEDLINE]Related articles

Comparing the psychometric properties of preference-based and nonpreference-based health-related quality of life in coronary heart disease. Canadian Collaborative Cardiac Assessment Group.

Lalonde L, Clarke AE, Joseph L, Mackenzie T, Grover SA.

Qual Life Res. 1999 Aug;8(5):399-409.PMID: 10474281 [PubMed - indexed for MEDLINE]Related articles

Estrogen replacement for women with cardiovascular disease: why don't physicians and patients follow the guidelines?

Grover SA.

CMAJ. 1999 Jul 13;161(1):42-3. No abstract available. PMID: 10420864 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.

Perreault S, Dorais M, Coupal L, Paradis G, Joffres MR, Grover SA.

CMAJ. 1999 May 18;160(10):1449-55. Erratum in: CMAJ 1999 Jul 13;161(1):21. PMID: 10352634 [PubMed - indexed for MEDLINE]Related articlesFree article

Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis.

Clarke AE, Levinton C, Joseph L, Penrod J, Zowall H, Sibley JT, Grover SA, Esdaile JM.

J Rheumatol. 1999 May;26(5):1068-75.PMID: 10332970 [PubMed - indexed for MEDLINE]Related articles

Conventional and chained standard gambles in the assessment of coronary heart disease prevention and treatment. Canadian Collaborative Cardiac Assessment Group.

Lalonde L, Clarke AE, Joseph L, Grover SA.

Med Decis Making. 1999 Apr-Jun;19(2):149-56.PMID: 10231077 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer: 12. The economic burden.

Grover SA, Zowall H, Coupal L, Krahn MD.

CMAJ. 1999 Mar 9;160(5):685-90. No abstract available. PMID: 10102004 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events.

Grover SA, Coupal L, Paquet S, Zowall H.

Arch Intern Med. 1999 Mar 22;159(6):593-600.PMID: 10090116 [PubMed - indexed for MEDLINE]Related articlesFree article

Identifying adults at low risk for significant hyperlipidemia: a validated clinical index.

Grover SA, Levinton C, Paquet S.

J Clin Epidemiol. 1999 Jan;52(1):49-55.PMID: 9973073 [PubMed - indexed for MEDLINE]Related articles

Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever.

White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO, Clare AW.

Br J Psychiatry. 1998 Dec;173:475-81.PMID: 9926075 [PubMed - indexed for MEDLINE]Related articles

Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis.

Morimura H, Fishman GA, Grover SA, Fulton AB, Berson EL, Dryja TP.

Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3088-93.PMID: 9501220 [PubMed - indexed for MEDLINE]Related articlesFree article

Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention.

Grover SA, Paquet S, Levinton C, Coupal L, Zowall H.

Arch Intern Med. 1998 Mar 23;158(6):655-62. Erratum in: Arch Intern Med 1998 Jun 8;158(11):1228. PMID: 9521231 [PubMed - indexed for MEDLINE]Related articlesFree article

Economics of prostate cancer: a computer model.

Grover SA.

Can J Urol. 1997 Jun;4(2 Supp 1):88-89.PMID: 12735845 [PubMed - as supplied by publisher]Related articles